


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.26%
+14.21%
+15.31%
+0.24%
-1.76%
MDXG
MiMedx Group Inc
$3.67

Login to see MiMedx Group Inc (MDXG) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Outperform the market

Earnings are forecast to grow
Risk Analysis

Downgraded on weak valued
MDXG Price Performance
$3.09 (+18.77%)
$4.88 (-24.80%)
$6.77 (-45.79%)
$6.53 (-43.80%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Outperform the market
Earnings are forecast to grow
MDXG Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MDXG Street Sentiment is extremely bullish and have negative views on the near-term outlook
MDXG has Medium risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Feb 23, 2026
Initiate
Outperform
Citizens
Dec 18, 2025
Reiterate
Outperform
Mizuho
May 09, 2026
Downgrade
Hold
NVO
Novo Nordisk A/S
44.19
-1.70%
SNY
Sanofi
44.15
-0.32%
ABUS
Arbutus Biopharma
4.64
+6.67%
What is MDXG current stock price?
What is MDXG current Stock IQ?
What is MDXG RSI signal right now?
What is MDXG analyst price target and upside potential?
What do analysts say about MDXG stock?
What is MDXG momentum trend right now?
What are MDXG stock strengths?
What is MDXG Risk Level?
Should I buy MDXG stock right now?
Is MDXG a Strong Buy right now?
What is MDXG market cap and volume?
What factors influence MDXG's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
MDXG
MiMedx Group Inc
Current Price
$3.67
NVO
Novo Nordisk A/S
44.19
-1.70%
SNY
Sanofi
44.15
-0.32%
ABUS
Arbutus Biopharma
4.64
+6.67%

MDXG Price Performance
$3.09 (+18.77%)
$4.88 (-24.80%)
$6.77 (-45.79%)
$6.53 (-43.80%)
MDXG Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Outperform the market
Earnings are forecast to grow
MDXG Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MDXG Street Sentiment is extremely bullish and have negative views on the near-term outlook
MDXG has Medium risk level

Overall Wall Street Rating
MDXG Stock IQ
Stock Insights
Strengths

Outperform the market

Earnings are forecast to grow
Risk Analysis

Downgraded on weak valued
MDXG Trading Signals
MDXG RSI crossed above 50, breaking into bullish territory (RSI: 51.2 vs previous 48.8)
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MDXG Stock trends
MDXG Stock performance
MDXG Stock analysis
MDXG investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.